S&P 500   5,253.05 (+0.09%)
DOW   39,778.57 (+0.05%)
QQQ   444.16 (-0.15%)
AAPL   171.75 (-0.90%)
MSFT   420.59 (-0.20%)
META   487.76 (-1.24%)
GOOGL   150.99 (+0.08%)
AMZN   180.23 (+0.22%)
TSLA   176.83 (-1.67%)
NVDA   904.14 (+0.18%)
NIO   4.52 (-3.21%)
AMD   180.34 (+0.42%)
BABA   72.47 (+1.23%)
T   17.65 (+0.57%)
F   13.22 (+1.23%)
MU   117.82 (-1.11%)
CGC   8.60 (-9.95%)
GE   175.08 (-2.80%)
DIS   122.45 (+1.22%)
AMC   3.68 (-15.21%)
PFE   27.93 (+0.54%)
PYPL   67.09 (+0.78%)
XOM   116.14 (+1.02%)
S&P 500   5,253.05 (+0.09%)
DOW   39,778.57 (+0.05%)
QQQ   444.16 (-0.15%)
AAPL   171.75 (-0.90%)
MSFT   420.59 (-0.20%)
META   487.76 (-1.24%)
GOOGL   150.99 (+0.08%)
AMZN   180.23 (+0.22%)
TSLA   176.83 (-1.67%)
NVDA   904.14 (+0.18%)
NIO   4.52 (-3.21%)
AMD   180.34 (+0.42%)
BABA   72.47 (+1.23%)
T   17.65 (+0.57%)
F   13.22 (+1.23%)
MU   117.82 (-1.11%)
CGC   8.60 (-9.95%)
GE   175.08 (-2.80%)
DIS   122.45 (+1.22%)
AMC   3.68 (-15.21%)
PFE   27.93 (+0.54%)
PYPL   67.09 (+0.78%)
XOM   116.14 (+1.02%)
S&P 500   5,253.05 (+0.09%)
DOW   39,778.57 (+0.05%)
QQQ   444.16 (-0.15%)
AAPL   171.75 (-0.90%)
MSFT   420.59 (-0.20%)
META   487.76 (-1.24%)
GOOGL   150.99 (+0.08%)
AMZN   180.23 (+0.22%)
TSLA   176.83 (-1.67%)
NVDA   904.14 (+0.18%)
NIO   4.52 (-3.21%)
AMD   180.34 (+0.42%)
BABA   72.47 (+1.23%)
T   17.65 (+0.57%)
F   13.22 (+1.23%)
MU   117.82 (-1.11%)
CGC   8.60 (-9.95%)
GE   175.08 (-2.80%)
DIS   122.45 (+1.22%)
AMC   3.68 (-15.21%)
PFE   27.93 (+0.54%)
PYPL   67.09 (+0.78%)
XOM   116.14 (+1.02%)
S&P 500   5,253.05 (+0.09%)
DOW   39,778.57 (+0.05%)
QQQ   444.16 (-0.15%)
AAPL   171.75 (-0.90%)
MSFT   420.59 (-0.20%)
META   487.76 (-1.24%)
GOOGL   150.99 (+0.08%)
AMZN   180.23 (+0.22%)
TSLA   176.83 (-1.67%)
NVDA   904.14 (+0.18%)
NIO   4.52 (-3.21%)
AMD   180.34 (+0.42%)
BABA   72.47 (+1.23%)
T   17.65 (+0.57%)
F   13.22 (+1.23%)
MU   117.82 (-1.11%)
CGC   8.60 (-9.95%)
GE   175.08 (-2.80%)
DIS   122.45 (+1.22%)
AMC   3.68 (-15.21%)
PFE   27.93 (+0.54%)
PYPL   67.09 (+0.78%)
XOM   116.14 (+1.02%)
NYSE:FNA

Paragon 28 (FNA) Stock Price, News & Analysis

$12.21
+0.30 (+2.52%)
(As of 02:21 PM ET)
Today's Range
$11.77
$12.50
50-Day Range
$8.87
$14.55
52-Week Range
$7.95
$19.72
Volume
373,069 shs
Average Volume
499,677 shs
Market Capitalization
$1.01 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.33

Paragon 28 MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
58.5% Upside
$19.33 Price Target
Short Interest
Bearish
5.10% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.32mentions of Paragon 28 in the last 14 days
Based on 7 Articles This Week
Insider Trading
Acquiring Shares
$255,360 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.42) to ($0.30) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.88 out of 5 stars

Medical Sector

354th out of 939 stocks

Surgical & Medical Instruments Industry

46th out of 98 stocks

FNA stock logo

About Paragon 28 Stock (NYSE:FNA)

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

FNA Stock Price History

FNA Stock News Headlines

Piper Sandler Keeps Their Buy Rating on Paragon 28 (FNA)
AI to Meet the Same Fate as EVs?
When these tech bubbles burst, they invariably leave investors disillusioned by their losses. Now, many worry a similar fate is awaiting AI. And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11…
Paragon 28 (NYSE:FNA) Shares Gap Up on Insider Buying Activity
AI to Meet the Same Fate as EVs?
When these tech bubbles burst, they invariably leave investors disillusioned by their losses. Now, many worry a similar fate is awaiting AI. And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11…
Q4 2023 Paragon 28 Inc Earnings Call
Recap: Paragon 28 Q4 Earnings
Earnings Outlook For Paragon 28
FNA May 2024 15.000 call
Paragon 28 Insider Ups Holding During Year
See More Headlines
Receive FNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Paragon 28 and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/29/2024
Today
3/28/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Fax
N/A
Employees
574
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$19.33
High Stock Price Target
$23.00
Low Stock Price Target
$17.00
Potential Upside/Downside
+62.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-47,840,000.00
Pretax Margin
-22.01%

Debt

Sales & Book Value

Annual Sales
$216.39 million
Book Value
$2.15 per share

Miscellaneous

Free Float
70,411,000
Market Cap
$987.45 million
Optionable
Optionable
Beta
1.02
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives


FNA Stock Analysis - Frequently Asked Questions

Should I buy or sell Paragon 28 stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Paragon 28 in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" FNA shares.
View FNA analyst ratings
or view top-rated stocks.

What is Paragon 28's stock price target for 2024?

4 equities research analysts have issued 12-month price objectives for Paragon 28's shares. Their FNA share price targets range from $17.00 to $23.00. On average, they anticipate the company's stock price to reach $19.33 in the next twelve months. This suggests a possible upside of 58.5% from the stock's current price.
View analysts price targets for FNA
or view top-rated stocks among Wall Street analysts.

How have FNA shares performed in 2024?

Paragon 28's stock was trading at $12.43 at the beginning of 2024. Since then, FNA stock has decreased by 1.9% and is now trading at $12.20.
View the best growth stocks for 2024 here
.

Are investors shorting Paragon 28?

Paragon 28 saw a increase in short interest in March. As of March 15th, there was short interest totaling 1,860,000 shares, an increase of 12.0% from the February 29th total of 1,660,000 shares. Based on an average daily volume of 482,300 shares, the short-interest ratio is currently 3.9 days. Approximately 5.1% of the shares of the company are sold short.
View Paragon 28's Short Interest
.

When is Paragon 28's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our FNA earnings forecast
.

How were Paragon 28's earnings last quarter?

Paragon 28, Inc. (NYSE:FNA) announced its quarterly earnings results on Thursday, February, 29th. The company reported ($0.19) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by $0.09. Paragon 28 had a negative trailing twelve-month return on equity of 22.51% and a negative net margin of 22.11%.

What guidance has Paragon 28 issued on next quarter's earnings?

Paragon 28 issued an update on its FY 2024 earnings guidance on Thursday, February, 29th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $249.0 million-$259.0 million, compared to the consensus revenue estimate of $256.1 million.

When did Paragon 28 IPO?

Paragon 28 (FNA) raised $125 million in an initial public offering (IPO) on Friday, October 15th 2021. The company issued 7,800,000 shares at $15.00-$17.00 per share. BofA Securities and Piper Sandler acted as the underwriters for the IPO and Canaccord Genuity, JMP Securities and Needham & Company were co-managers.

Who are Paragon 28's major shareholders?

Paragon 28's stock is owned by many different institutional and retail investors. Top institutional shareholders include MVM Partners LLC (13.16%), First Light Asset Management LLC (4.62%), Vanguard Group Inc. (2.48%), Vanguard Group Inc. (2.48%), Point72 Asset Management L.P. (1.55%) and Park Edge Advisors LLC (0.71%). Insiders that own company stock include Albert Dacosta, B Ag Bird, Frank S Bono, Kristina Wright, Lee Rosenthal, Matthew Jarboe, Mvm Partners Llp and Thomas P Schnettler.
View institutional ownership trends
.

How do I buy shares of Paragon 28?

Shares of FNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:FNA) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners